Benjamin Izar
Impact in
- Immunology top 0.5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 47
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 14
- Immunology 31
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 8
- Immune Cell Function and Interaction 8
- Co-authors
- Peter Karl Sorger (5 shared papers)Jia‐Ren Lin (3 shared papers)Sandro Santagata (3 shared papers)Shu Wang (2 shared papers)Parin Shah (6 shared papers)Shaolin Mei (2 shared papers)Clarence Yapp (1 shared paper)Levi A. Garraway (4 shared papers)
- Journals
- Cell (7 papers)Nature (7 papers)Nature Medicine (6 papers)Journal for ImmunoTherapy of Cancer (5 papers)Nature Cancer (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Benjamin Izar
92 papers receiving 12.7k citations
Benjamin Izar's Hit Papers
Peers
Comparison fields: 5 of 141
- Immunology 3.6k
- Cancer Research 2.2k
- Oncology 4.0k
- Biophysics 679
- Molecular Biology 6.3k
Countries citing papers authored by Benjamin Izar
This map shows the geographic impact of Benjamin Izar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Izar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Izar more than expected).
Fields of papers citing papers by Benjamin Izar
This network shows the impact of papers produced by Benjamin Izar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Izar. The network helps show where Benjamin Izar may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Izar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq Hit paper breakdown → | 2016 | 3421 |
| 2 | A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade Hit paper breakdown → | 2018 | 1015 |
| 3 | Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma Hit paper breakdown → | 2016 | 860 |
| 4 | COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets Hit paper breakdown → | 2021 | 577 |
| 5 | Spatially organized multicellular immune hubs in human colorectal cancer Hit paper breakdown → | 2021 | 571 |
| 6 | A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors Hit paper breakdown → | 2020 | 491 |
| 7 | Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids Hit paper breakdown → | 2017 | 484 |
| 8 | A molecular single-cell lung atlas of lethal COVID-19 Hit paper breakdown → | 2021 | 476 |
| 9 | Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes Hit paper breakdown → | 2018 | 475 |
| 10 | The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution Hit paper breakdown → | 2020 | 375 |
| 11 | A single-cell landscape of high-grade serous ovarian cancer Hit paper breakdown → | 2020 | 363 |
| 12 | Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis Hit paper breakdown → | 2022 | 254 |
| 13 | 2020 | 244 | |
| 14 | Non-cell-autonomous cancer progression from chromosomal instability Hit paper breakdown → | 2023 | 209 |
| 15 | 2017 | 184 | |
| 16 | 2021 | 165 | |
| 17 | 2017 | 155 | |
| 18 | 2022 | 140 | |
| 19 | 2021 | 127 | |
| 20 | 2019 | 102 |
About Benjamin Izar
Benjamin Izar is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 98 papers that have together received 12.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Single-cell and spatial transcriptomics (21 papers), Cancer Genomics and Diagnostics (15 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (11 papers), Melanoma and MAPK Pathways (11 papers), Immune cells in cancer (8 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Immunology (3.6k citations), Cancer Research (2.2k citations), Oncology (4.0k citations), Biophysics (679 citations) and Molecular Biology (6.3k citations). Benjamin Izar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Peter Karl Sorger, Jia‐Ren Lin, Sandro Santagata, Shu Wang, Parin Shah, Shaolin Mei, Clarence Yapp, Levi A. Garraway, Asaf Rotem and Torsten Hain. Their work appears in journals such as Cell, Nature, Nature Medicine, Journal for ImmunoTherapy of Cancer and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.